Dasatinib
- OralDasatinibSprycelBinds both active & inactive conformation of Bcr-Abl kinase, resulting in reduced resistance
- Mechanism of Action
- Inhibits the Bcr-Abl tyrosine kinase as well as the stem cell receptor factor (cKIT) and several other receptor tyrosine kinases.
Clinical Use
- Indications
- Adverse Effects